Back to top

Amgen Inc: (AMGN)

(Market Close from NSDQ) As of Jan 26, 2015 04:00 PM ET

 Add to portfolio

 ZacksTrade Now

$159.73 USD

159.73
3,146,089

-0.08 (-0.05%)

Volume: 3,146,089

Zacks Rank : 1-Strong Buy [?] 1        

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

General Information

AMGEN INC

ONE AMGEN CENTER DRIVE

THOUSAND OAKS, CA 91320

Phone: 805-447-1000

Fax: 805-447-1010

Web: http://www.amgen.com

Email: investor.relations@amgen.com

Industry MED-BIOMED/GENE
Sector Medical
Fiscal Year End December
Last Reported Quarter 12/31/2014
Next EPS Date 1/27/2015

EPS Information

Current Quarter EPS Consensus Estimate 2.05
Current Year EPS Consensus Estimate 8.59
Estimated Long-Term EPS Growth Rate 9.20
Next EPS Report Date 1/27/2015

Price and Volume Information

Zacks Rank
Yesterday's Close 159.81
52 Week High 173.14
52 Week Low 108.20
Beta 0.52
20 Day Moving Average 2,964,286.25
Target Price Consensus 165.38

AMGN

% Price Change
4 Week -0.54
12 Week -1.10
YTD 0.33
% Price Change Relative to S&P 500
4 Week 0.92
12 Week -3.85
YTD -0.03
Share Information
Shares Outstanding (millions) 760.67
Market Capitalization (millions) 121,562.67
Short Ratio 2.69
Last Split Date 11/22/1999
Dividend Information
Dividend Yield 1.53%
Annual Dividend $2.44
Payout Ratio 0.29
Change in Payout Ratio NA
Last Dividend Payout / Amount 11/10/2014 / $0.61

Fundamental Ratios

P/E
P/E (F1) 17.08
Trailing 12 Months 19.16
PEG Ratio 1.86
EPS Growth
vs. Previous Year 19.17%
vs. Previous Quarter -2.95%
   
Sales Growth
vs. Previous Year 5.96%
vs. Previous Quarter -2.88%
   
Price Ratios
Price/Book 4.80
Price/Cash Flow 17.03
Price / Sales 6.16
ROE
12/31/14 NA
9/30/14 27.11
6/30/14 26.88
ROA
12/31/14 NA
9/30/14 9.37
6/30/14 9.41
Current Ratio
12/31/14 NA
9/30/14 4.22
6/30/14 4.36
Quick Ratio
12/31/14 NA
9/30/14 3.88
6/30/14 3.99
Operating Margin
12/31/14 NA
9/30/14 32.45
6/30/14 31.40
Net Margin
12/31/14 NA
9/30/14 24.74
6/30/14 25.74
Pre-Tax Margin
12/31/14 NA
9/30/14 26.91
6/30/14 28.16
Book Value
12/31/14 NA
9/30/14 33.28
6/30/14 32.21
Inventory Turnover
12/31/14 NA
9/30/14 1.44
6/30/14 1.35
Debt-to-Equity
12/31/14 NA
9/30/14 1.20
6/30/14 1.26
Debt to Capital
12/31/14 NA
9/30/14 54.62
6/30/14 55.84